Vanda Pharmaceuticals Inc (LTS:0LKB)
$ 5.0312 -0.1487 (-2.87%) Market Cap: 293.87 Mil Enterprise Value: -74.45 Mil PE Ratio: 0 PB Ratio: 0.54 GF Score: 64/100

Vanda Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 13, 2021 / 03:00PM GMT
Release Date Price: $17.97 (-1.02%)
Olivia Simone Brayer
BofA Securities, Research Division - Associate

All right. Good morning, everyone, and welcome to our final day of our BofA Virtual -- BofA Health Care Conference. My name is Olivia Brayer, and I'm on the U.S. biopharma team here at Bank of America. And we're very happy to have with us today, the CEO of Vanda Pharmaceuticals, Mihales Polymeropoulos. We did just launch on Vanda earlier this week, so let us know if you need our model or report. Happy to send either of those. But thanks so much for being with us today, Mihales.

Mihael H. Polymeropoulos
Vanda Pharmaceuticals Inc. - Founder, President, CEO & Director

Thank you, Olivia.

Olivia Simone Brayer
BofA Securities, Research Division - Associate

Yes. And just quickly before we begin, Vanda does have their latest corporate deck on the webcast. So feel free to check that out during the Q&A. You can also submit questions for Mihales and the Vanda team via the link.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot